
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease
Author(s) -
Abdullah Kutlar,
Kenneth I. Ataga,
Marvin Reid,
Elliott Vichinsky,
Lynne Neumayr,
Loray Blair-Britt,
Richard Labotka,
Jonathan D. Glass,
Jeffrey R. Keefer,
William A. Wargin,
Ronald J. Berenson,
Susan P. Perrine
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/r612-td45
Subject(s) - inducer , disease , cell , medicine , fetus , fetal hemoglobin , biology , genetics , gene , pregnancy